{"id":79244,"date":"2026-06-08T04:18:20","date_gmt":"2026-06-08T04:18:20","guid":{"rendered":"https:\/\/www.europesays.com\/ch\/79244\/"},"modified":"2026-06-08T04:18:20","modified_gmt":"2026-06-08T04:18:20","slug":"roche-bets-splits-in-obesity-market-will-open-door-to-new-entrants-2","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ch\/79244\/","title":{"rendered":"Roche Bets Splits in Obesity Market Will Open Door to New Entrants"},"content":{"rendered":"<p data-type=\"paragraph\" data=\"[object Object]\" class=\"css-1qg6i2u eku5yup0\"><a data-type=\"company\" href=\"https:\/\/www.wsj.com\/market-data\/quotes\/CH\/XSWX\/RO\" target=\"_blank\" class=\"ekxajjj0 css-i0lbhy-OverridedLink\" rel=\"nofollow noopener\">Roche Holding<\/a> expects the <a data-type=\"subject\" href=\"https:\/\/www.wsj.com\/topics\/subject\/obesity\" target=\"_blank\" class=\"ekxajjj0 css-i0lbhy-OverridedLink\" rel=\"nofollow noopener\">obesity<\/a> market to split into segments as weight-loss drugs reach the wider public, opening the door for new players to take on <a data-type=\"company\" href=\"https:\/\/www.wsj.com\/market-data\/quotes\/LLY\" target=\"_blank\" class=\"ekxajjj0 css-i0lbhy-OverridedLink\" rel=\"nofollow noopener\">Eli Lilly<\/a> and <a data-type=\"company\" href=\"https:\/\/www.wsj.com\/market-data\/quotes\/DK\/XCSE\/NOVO.B\" target=\"_blank\" class=\"ekxajjj0 css-i0lbhy-OverridedLink\" rel=\"nofollow noopener\">Novo Nordisk<\/a>.<\/p>\n<p data-type=\"paragraph\" data=\"[object Object]\" class=\"css-1qg6i2u eku5yup0\">\u201cWe are literally scratching the surface, and underneath that is a whole world of unmet needs that patients are desperately waiting for,\u201d said Manu Chakravarthy, Roche\u2019s global head of cardiovascular, renal and metabolism product development and one of the executives in charge of leading the pharmaceutical giant\u2019s bid to re-enter the obesity market.<\/p>\n<p class=\"css-16aepit e1jdulti0\">Copyright \u00a92026 Dow Jones &amp; Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8<\/p>\n","protected":false},"excerpt":{"rendered":"Roche Holding expects the obesity market to split into segments as weight-loss drugs reach the wider public, opening&hellip;\n","protected":false},"author":2,"featured_media":79245,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[124],"tags":[41200,4617,1126,6273,41203,216,16097,2783,1002,4128,25348,6288,1831,41205,41201,41204,228,25357,6263,2233,41202,1813,337,10728,25356,134,994,39268,5049,3381,41199,6278,6279],"class_list":["post-79244","post","type-post","status-publish","format-standard","has-post-thumbnail","category-roche","tag-chro","tag-community","tag-corporate","tag-corporate-industrial-news","tag-dknovo-b","tag-eli-lilly","tag-gcapi","tag-general-news","tag-health","tag-healthcare","tag-healthcare-life-sciences","tag-industrial-news","tag-life-sciences","tag-linkendrnrealtime-linkedarticle-dnco20260319001424","tag-lly","tag-manu-chakravarthy","tag-manufacturing","tag-medical-conditions","tag-newsplus","tag-novo-nordisk","tag-novo-b-ko","tag-obesity","tag-pharmaceuticals","tag-political","tag-political-general-news","tag-roche","tag-roche-holding","tag-rog-eb","tag-social-issues","tag-society","tag-society-community","tag-synd","tag-wsj-pro-wsj-com"],"share_on_mastodon":{"url":"","error":"Validation failed: Text character limit of 500 exceeded"},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/79244","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/comments?post=79244"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/79244\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media\/79245"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media?parent=79244"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/categories?post=79244"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/tags?post=79244"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}